Bunge (BG) is close to getting a ruling from Chinese regulators on its $8.2B purchase of Glencore-backed (GLNCY) Viterra with a verdict expected within days, Bloomberg’s Isis Almeida and Hallie Gu report. Regulatory approval in China remains among the last remaining hurdles to the deal’s closing, as the deal has already received key approvals in the EU and Canada.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG:
